Delivery Order SPE2DB24D1201-SPE2DB25FJEAH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,121.70 to AmerisourceBergen Drug Corp for the supply of Methylphenidate Extended Release 27 mg tablets in a quantity of 100 units. This is a firm fixed price delivery order with no set-aside designation, executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count packages) with a contract value of $2,196.52. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively determined. The order is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with a contract ceiling value of $4,365.39. This is a firm fixed price delivery order under a competitively awarded, non-set-aside contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,448.52 to supply Methylphenidate ER 36 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,565.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.08 for methylphenidate ER 36 mg tablets (100-count supply) on July 22, 2025, with ultimate completion by July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with a ceiling value of $2,358.46. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and is...
- The Defense Logistics Agency awarded a delivery order valued at $2,884.88 to AmerisourceBergen Drug Corp for Methylphenidate Extended-Release 36 mg tablets (100-count supply). This firm fixed-price delivery order, issued on August 19, 2025, with completion targeted for August 20, 2025, represents a competitively awarded contract with no set-aside designation. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a $1,479.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,544.82. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The product will be delivered to the...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEAHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylphenidate Extended-Release 36 mg tablets in quantities of 100 units. This contract, valued at $1,697.25, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal military and veteran healthcare procurement. The company's DLA Troop Support Medical contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. This delivery order for methylphenidate, a commonly prescribed medication for attention-related disorders, exemplifies the routine pharmaceutical fulfillment activities executed under this expansive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/28/25 |